Introduction {#s1}
============

Innate immunity comprises the first line of defense against invading micro-organisms. The presence of pathogen associated molecular patterns (PAMPs) or damage associated molecular patterns (DAMPs) activates conserved signaling pathways to protect the host and bring infection under control ([@bib55]). Over the last several decades, several powerful invertebrate models including the round worm *Caenorhabditis elegans* have provided significant and unique insights into underlying mechanisms of innate immunity ([@bib42]). Pioneering studies demonstrated that evolutionarily conserved core signaling pathways including mitogen-activated protein kinase (MAPK) cascades ([@bib19]), HLH-30/TFEB signaling ([@bib48]) and β-catenin signaling ([@bib17]) regulate innate immunity from worms to mammals.

In *C. elegans*, the MAPK cascade of NSY-1-SEK-1-PMK-1 is essential to innate immunity, and has orthologs in mammals (ASK1 MAPKKK-MKK3/6 MAPKK-p38 MAPK pathway) playing a similar role ([@bib19]). This signaling in *C. elegans* depends on TIR-1, a Toll-Interleukin-1 Receptor (TIR) domain protein and an ortholog of mammalian SARM ([@bib9]). Deletion mutants of the *C. elegans* PMK-1 pathway correspondingly exhibit dysregulated transcriptional responses and hypersensitivity to infection challenge ([@bib14]; [@bib19]; [@bib46]). Evidently, pattern recognition receptors (PRRs), such as Toll-like-receptors, which function upstream to control the MAPK pathway in mammals and insects, do not appear to play a significant role in *C. elegans* infection responses ([@bib33]; [@bib34]), but rather mediate the aversive behavioral response to pathogens ([@bib5]). G protein-coupled receptors (GPCRs) apparently play an important role in controlling the MAPK pathway in *C. elegans* in the context of infection ([@bib36]; [@bib37]; [@bib56]). However, identities of the actual ligands during infection for these receptors are not clear except for *dcar-1*, whose ligand was identified to be an endogenous molecule, 4-hydroxyphenyllactic acid (HPLA) ([@bib56]). Various stressors also trigger the MAPK pathway, but how these different inputs activate MAPK cascades in *C. elegans* is not well understood.

mRNA splicing is an essential process in eukaryotic cells whereby intervening non-coding sequences (introns) are removed from primary transcripts, and protein coding sequences (exons) are joined together to form the mature mRNA. This activity is catalyzed by a family of specialized proteins called splicing factors ([@bib49]). Different combinations of exons enlarge the repertoire of proteins and thus increase diversity of molecules at play in the physiological response. Various physiological processes are regulated by splicing in *C. elegans*, including heavy metal resistance, metabolism and lifespan ([@bib16]; [@bib41]; [@bib50]), yet how splicing affects innate immunity, especially in invertebrate models, remains relatively unexplored. Here we report a novel role of splicing factors in immunity that reveal a crucial host response during bacterial infection.

Results {#s2}
=======

G281D substitution of RNP-6 enhances resistance to abiotic stresses {#s2-1}
-------------------------------------------------------------------

Cellular stress resistance mechanisms help manage diverse environmental and physiologic challenges. Animals have evolved adaptive mechanisms to survive heat and cold stress ([@bib28]; [@bib35]). While heat stress mechanisms have been well studied, cold stress mechanisms are not well understood ([@bib29]). We observed that 2°C cold stress rapidly killed *C. elegans* wildtype N2 animals ([Figure 1A](#fig1){ref-type="fig"}), while long-lived strains such as *daf-2*/InsR and *eat-2* dietary restriction mutants were remarkably resistant ([Figure 1B](#fig1){ref-type="fig"}). In order to identify novel cold stress resistant loci, we performed an EMS screen for mutants able to withstand prolonged exposure (72 hr) to 2°C and recover to reproduce at normal growing temperature of 20°C ([Figure 1C](#fig1){ref-type="fig"}). Surviving mutants were outcrossed, and causative mutations were identified using genome sequencing and single-nucleotide polymorphism mapping (data not shown). Two screenings were conducted with 16000 haploid genomes screened. A total of 303 cold resistant mutants were recovered.

![Isolation of the *rnp-6* G281D substitution mutant from a cold resistance screen.\
(**A**) Cold stress survival assay. Low temperature (2°C) incubation kills wildtype young adult worms. (**B**) *daf-2* and *eat-2* mutants show enhanced survival after 24 hr incubation at 2°C. (**C**) Schematic of the cold stress selection experiment. (**D**) Schematic showing the location of the G281D mutation in *rnp-6*. RRM stands for RNA recognition motif. The glycine at this position is conserved in human (*Homo sapiens*), mouse (*Mus musculus*) and fruit fly (*Drosophila melanogaster*). (**E**) The CRISPR strain (*dh1127*) shows the same cold resistant phenotype as the original mutant (*dh1124*) isolated from the genetic screen. (**F**) The *rnp-6* G281D mutant shows enhanced survival under 35°C heat stress. (**G**) The *rnp-6* G281D mutant shows improved survival under oxidative stress (20 mM paraquat) (p\<0.0001, log-rank test.). (**H,I,J**) Infection survival analysis. *rnp-6(dh1127)* animals show sensitivity to all the bacteria tested. *S. aureus* (p\<0.0001, log-rank test.), *E. faecalis* (p\<0.0001, log-rank test.) and *P. aeruginosa* (p=0.0022, log-rank test.). The *hlh-30* mutant serves as a positive control of infection sensitivity. (**K**) Demographic analysis of lifespan. *rnp-6(dh1127)* mutants have significant lifespan extension when cultured with OP50 bacteria at 20°C (p\<0.0001, log-rank test.). Survival and lifespan experiments were performed three times independently. Error bars represent mean ± s.e.m. \*p\<0.05, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired t-test.](elife-57591-fig1){#fig1}

From the screen, we identified a novel mutation in *rnp-6*, which encodes an ortholog of the mammalian splicing factor Poly(U) Binding Splicing Factor 60 (PUF60). PUF60 facilitates the association of the U2 snRNP with target RNA molecules ([@bib32]). PUF60 is essential, and heterozygous loss of function causes Verheij syndrome, which is characterized by severe developmental abnormalities in most patients ([@bib22]; [@bib47]). PUF60 is also involved in Hepatitis B virus infection ([@bib39]) and cancer progression ([@bib40]). In *C. elegans*, we found a G281D amino acid substitution in *rnp-6* lying within the second RNA binding motif at a position conserved across evolution ([Figure 1D](#fig1){ref-type="fig"}). Surprisingly, this mutation confers no obvious developmental phenotypes, despite *rnp-6* null mutants being embryonic lethal ([@bib18]). Upon outcrossing the original mutant, *rnp-6(dh1124)* was highly resistant to cold stress ([Figure 1E](#fig1){ref-type="fig"}). An independent line carrying the same mutation (*dh1127*) was created using CRISPR gene editing, which showed the same phenotype, confirming the casual relation ([Figure 1E](#fig1){ref-type="fig"}). In subsequent experiments, we used the CRISPR line. The mutant had a slightly reduced brood size ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), a slight but significant developmental delay (around 3.5 hr more to reach adulthood) ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) and a marginally shorter body size ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}), but did not significantly affect pharyngeal pumping rate ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). Interestingly, the mutant was also resistant to heat stress ([Figure 1F](#fig1){ref-type="fig"}) and oxidative stress ([Figure 1G](#fig1){ref-type="fig"}), suggesting this mutation widely confers resistance to multiple abiotic stresses.

G281D substitution of RNP-6 causes infection sensitivity {#s2-2}
--------------------------------------------------------

*C. elegans* mutants that are resistant to abiotic stresses often have better survival upon infectious insults and are long-lived ([@bib15]; [@bib43]). To test whether the stress resistant *rnp-6* G281D mutant also enhances infection survival, we infected the *rnp-6(dh1127)* mutant with different pathogenic bacteria, namely *Staphylococcus aureus*, *Enterococcus faecalis* and *Pseudomonas aeruginosa*. Unexpectedly, this mutant was more sensitive to all pathogenic bacteria tested ([Figure 1H--J](#fig1){ref-type="fig"}). This phenotype was confirmed with another independently created CRISPR line (*dh1125*) ([Figure 1---figure supplement 1E--G](#fig1s1){ref-type="fig"}). We also performed the experiments on full lawn *S. aureus* plates. The *rnp-6(dh1127)* mutant displayed the same sensitive phenotype ([Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}), suggesting the sensitivity was not due to differential bacterial exposure. Although *rnp-6(dh1127)* animals were more sensitive to *S. aureus*, we did not observe a difference in bacterial burden ([Figure 1---figure supplement 1I](#fig1s1){ref-type="fig"}). Interestingly, when cultured with the weakly pathogenic *E. coli* strain OP50, the *rnp-6(dh1127)* mutant showed robust longevity at 20°C ([Figure 1K](#fig1){ref-type="fig"}) and a normal lifespan at 25°C ([Figure 1---figure supplement 1J](#fig1s1){ref-type="fig"}), indicating the shortened survival on pathogenic bacteria was specific and unlikely due to general sickness of the mutant. Although longevity is dependent on temperature, the mutant was sensitive to pathogenic bacterial infection at both 20°C and 25°C ([Figure 1---figure supplement 1K](#fig1s1){ref-type="fig"}). Taken together, the data suggest G281D substitution of *rnp-6* enhances abiotic stress resistance, prolongs lifespan, but specifically compromises infection survival.

Next, we assessed the levels of RNP-6 upon infection. Using CRISPR technology, we tagged endogenous RNP-6 with a N-terminal HA tag (*dh1188*). We performed qRT-PCR and western blots to detect the endogenous levels of RNP-6 at both transcript and protein levels. However, no significant changes could be detected after *S. aureus* infection ([Figure 1---figure supplement 1L,M](#fig1s1){ref-type="fig"}). We conclude that although RNP-6 profoundly affects infection survival, its levels remain stable upon infection in *C. elegans*.

G281D substitution of RNP-6 leads to dysregulation of immune responses {#s2-3}
----------------------------------------------------------------------

To further investigate the effect of RNP-6 on infection responses, we performed transcriptomic profiling of wildtype N2 animals and the *rnp-6* G281D mutant, under both control *E. coli* OP50 and *S. aureus* infected conditions. The *rnp-6* G281D mutation led to numerous differentially expressed genes (DEGs) under both non-infected (1483 genes) ([Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}) and infected conditions (1707 genes) ([Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"}). Under both conditions, Gene Ontology (GO) term analysis of the DEGs revealed an enrichment of genes implicated in immunity ([Figure 2A,B](#fig2){ref-type="fig"}). 662 genes were found to be induced by *S. aureus* infection in the N2 background. For 116 of them, the expression was dampened in the *rnp-6* mutant under infection ([Figure 2C](#fig2){ref-type="fig"}) ([Figure 2---source data 3](#fig2sdata3){ref-type="supplementary-material"}), and these *rnp-6* dependent infection induced genes were enriched for immune response genes ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Conversely, 1536 genes were repressed by *S. aureus* infection, and the expression remained higher in the *rnp-6* mutant for 159 of them ([Figure 2D](#fig2){ref-type="fig"}) ([Figure 2---source data 4](#fig2sdata4){ref-type="supplementary-material"}). Among these *rnp-6* dependent infection repressed genes, metabolic genes appeared to be highly enriched ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The most enriched GO terms included organic acid metabolic process and fatty acid metabolic process ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}).

![Dysregulation of immune responses in the *rnp-6* G281D mutant.\
(**A,B**) GO enrichment analysis using DAVID. RNA sequencing was performed on WT and *rnp-6(dh1127)* animals under control and *S. aureus* infected conditions. The 10 most statistically significant terms (based on p-values) are depicted for each comparison (p-values ascending). The enrichment (x axis), fold change (colour coding) and number of genes are shown. (**C**) Venn diagrams showing the numbers of up-regulated genes by infection and genes that are down-regulated in infected *rnp-6(dh1127)* when compared to infected N2 animals. *rnp-6* dependent infection induced gene are defined as the interception between the two set of genes. (**D**) Venn diagrams of genes that are down-regulated upon infection and genes that are up-regulated in infected *rnp-6(dh1127)* when compared to infected wildtype animals. *rnp-6* dependent infection repressed genes are defined as the interception between the two set of genes. (**E**) qRT-PCR results showing *rnp-6* G281D substitution compromises induction of antimicrobial genes (*nlp-30*, *nlp-34*, *spp-1* and *ilys-2*) upon *S. aureus* infection. Metabolic genes (*nhr-62*, *nhr-3*, *cth-1* and *fat-5*), which are suppressed in wildtype animals upon infection, maintain a higher expression in the *rnp-6(dh1127)* mutant. Error bars represent mean ± s.e.m. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired t-test.\
Figure 2---source data 1.List of differentially expressed genes.Non-infected.\
Figure 2---source data 2.List of differentially expressed genes.Infected.\
Figure 2---source data 3.List of *rnp-6* dependent infection induced genes.\
Figure 2---source data 4.List of *rnp-6* dependent infection repressed genes.](elife-57591-fig2){#fig2}

qRT-PCR was performed on selected genes. Consistent with the results from RNA sequencing, infection induced expression of antimicrobial proteins (*nlp-30*, *nlp-34* and *spp-1*) and lysozyme (*ilys-2*) was severely compromised by *rnp-6* G281D substitution ([Figure 2E](#fig2){ref-type="fig"}). Other categories of infection induced genes were also affected by *rnp-6* ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). On the other hand, the expression of nuclear hormone receptors (*nhr-62* and *nhr-3*) and metabolic enzymes (*cth-1* and *fat-5*) was refractory to the repression by infection in the *rnp-6* G281D mutant ([Figure 2E](#fig2){ref-type="fig"}). All in all, we conclude that G281D substitution of RNP-6 causes dysregulation of immune functions and inhibits transcriptional responses to bacterial infection.

RNP-6 regulates splicing effects of bacterial infection {#s2-4}
-------------------------------------------------------

We next wondered whether splicing was affected by the *rnp-6* G281D mutation. We analyzed splicing patterns of the transcriptomic data using Cufflinks ([@bib45]) and KISSDE ([@bib21]) protocols. 83 genes ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}) were found to be alternatively spliced upon *S. aureus* infection in wildtype animals. When comparing infected wildtype animals and infected *rnp-6(dh1127)* mutants, we found a larger number of alternatively spliced genes (456 genes) ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}). The number of alternatively spliced genes induced by *S. aureus* could be underestimated as a result of the short infection time used (4 hr post-infection) and tissue-specific alternative splicing masked in the transcriptome from whole animals. Over half of the genes (43 out of 83) ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}) showing infection induced alternative splicing, were also altered in the infected *rnp-6(dh1127)* mutants when compared to infected wildtype N2 animals. This suggests that the splicing alteration induced by infection is partly dependent on *rnp-6*. We also analyzed the data with the SAJR algorithm, which gives a detailed classification of the splicing events ([@bib25]). In wildtype animals, *S. aureus* infection induced splicing events were predominated by 'cassette exon' (44.9%) and 'retained intron' (22.4%). This was also true when we compared infected *rnp-6(1127)* mutants with infected wildtype animals ('cassette exon' 59.5%, 'retained intron' 15.2%) ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}). Using RT-PCR and agarose electrophoresis, we analyzed the splicing patterns of *prg-2, gyg-1* and *tos-1*. whose splicing is both infection and *rnp-6* dependent. *S. aureus* infection enhanced intron one splicing in *prg-2* in wildtype animals, but this effect was substantially suppressed in the *rnp-6(dh1127)* mutants ([Figure 3B](#fig3){ref-type="fig"}). Infection also led to inclusion of exon 6 and exon 7 of *gyg-1*, and again this effect was largely suppressed by the G281D substitution in the *dh1127* mutants ([Figure 3C](#fig3){ref-type="fig"}). Further, infection increased the abundance of the short *tos-1* isoform in wildtype animals ([Figure 3D](#fig3){ref-type="fig"}). Intriguingly, the *rnp-6* G281D mutants had an increased longer to shorter isoform ratio under non-infected condition, and this ratio remained the same after infection ([Figure 3D](#fig3){ref-type="fig"}), suggesting it is refractory to input. Taken together, these data show that bacterial infection induces an RNP-6 dependent splicing remodeling in *C. elegans*.

![*rnp-6* remodels alternate splicing patterns upon infection.\
(**A**) Venn diagrams showing the numbers of alternatively spliced genes induced by *S. aureus* infection and those that are affected in infected *rnp-6(dh1127)* when compared to infected N2 animals. (**B,C,D**) Agarose gel analysis of RT-PCR products of *prg-2, gyg-1* and *tos-1*. In wildtype animals, *S. aureus* infection induces a shift in splicing patterns, which is suppressed in the *rnp-6* G281D mutants. Error bars represent mean ± s.e.m. \*p\<0.05, \*\*p\<0.01, ns non-significant, unpaired t-test.\
Figure 3---source data 1.List of alternatively spliced genes upon *S. aureus* infection in wildtype animals.\
Figure 3---source data 2.List of alternatively spliced genes between infected wildtype animals and infected *rnp-6(dh1127)* mutants.\
Figure 3---source data 3.List of genes whose splicing is affected by both infection and *rnp-6*.](elife-57591-fig3){#fig3}

The activity of RNP-6 impairs immunity {#s2-5}
--------------------------------------

The G281D substitution of *rnp-6* compromises immunity ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), but how this substitution affects RNP-6 activity still remains elusive. We next sought to investigate the link between the activity levels of RNP-6 and innate immunity. Surprisingly, RNAi knockdown of *rnp-6* resulted in a robust extension of survival upon *S. aureus* infection ([Figure 4A](#fig4){ref-type="fig"}). Knock-down of many essential genes is reported to induce microbial aversion ([@bib26]). To test whether the survival phenotype of *rnp*-6 RNAi is due to reduced exposure to bacteria, we repeated the survival experiment using full lawn plates on which bacterial avoidance is impossible. RNAi against *rnp-6* still conferred enhanced survival under these conditions ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), ruling out the possibility that the phenotype is caused by differential bacterial exposure. Further, *rnp-6* RNAi did not affect *S. aureus* bacterial burden, suggesting the survival phenotype is caused by independent mechanisms ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}).

![RNP-6 restrains innate immunity in *C. elegans*.\
(**A**) Infection survival analysis. Young adult worms fed with either control or *rnp-6* RNAi HT115 bacteria were infected with *S. aureus. rnp-6* RNAi leads to prolonged survival (p\<0.0001, log-rank test.). (**B**) qRT-PCR results showing that wildtype animals grown on *rnp-6* RNAi HT115 bacteria have elevated levels of immune-related genes. (*nlp-34* p=0.0184, *lys-3* p=0.0132, *irg-2* p\<0.0001, *irg-1* p=0.0002, *M01G12.9* p=0.0002, *fmo-2* p=0.0021, *cyp-37B1* p\<0.0001, unpaired t-test.). 'A' denotes genes that are repressed in the *rnp-6* G281D mutant under infection condition. 'B' denotes genes that are also slightly induced in the *rnp-6* G281D mutant. Error bars represent mean ± s.e.m. (**C,D**) Agarose gel analysis of RT-PCR products of *prg-2* and *tos-1*. In wildtype animals, *rnp-6* RNAi (OP50) induces a shift in splicing patterns. (**E**) RNP-6 overexpressing strains show enhanced sensitivity upon infection with *S. aureus* (RNP-6 OE \#1, p\<0.0001, RNP-6 OE \#2 P\<0.0001, RNP-6 OE \#3 p=0.0006, log-rank test). (**F**) Demographic analysis of lifespan. Overexpression of RNP-6 prolongs lifespan when the animals are cultured with*E. coli*OP50 at 25°C (p\<0.0001, log-rank test.). Survival and lifespan experiments were performed three times independently. Error bars represent mean ± s.e.m. \*p\<0.05, \*\*p\<0.01, unpaired t-test.](elife-57591-fig4){#fig4}

Consistent with the survival results, *rnp-6* RNAi strongly induced the expression of numerous infection responsive genes, including *nlp-34*, *lys-3*, *irg-2*, *irg-1*, *M01G12.9*, *fmo-2* and *cyp-37B1* ([Figure 4B](#fig4){ref-type="fig"}). These findings suggest that RNP-6 normally suppresses immunity, and that reduction of function by RNAi derepresses immunity. Notably, among the genes that are transcriptionally induced by *rnp-6* RNAi, several of the same genes, namely *nlp-34*, *M01G12.9* and *cyp-37B1*, were suppressed by the *rnp-6* G281D substitution under *S. aureus* infection ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). The G281D substitution mutation, in this regard, behaved oppositely to *rnp-6* RNAi (marked with A in [Figure 4B](#fig4){ref-type="fig"}). In addition, other genes highly induced by *rnp-6* RNAi, such as *lys-3* and *fmo-2* ([Figure 4B](#fig4){ref-type="fig"}), were unaffected by the *rnp-6* G281D substitution under infection conditions ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Moreover, the levels of *lys-3*, *irg-2*, *irg-1* and *fmo-2* (marked with B in [Figure 4B](#fig4){ref-type="fig"}), which were induced upon *rnp-6* RNAi, were also slightly elevated in the *rnp-6* G281D mutants under non-infected condition ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). These results indicate that *rnp-6* G281D substitution and *rnp-6* RNAi resulted in partially overlapping and partially opposite transcriptional responses of immune genes.

Next, we assessed how *rnp-6* RNAi affects splicing by measuring *prg-2, tos-1* and *gyg-1* transcripts as above. Splicing of *prg-2* and *tos-1*, which exhibited *rnp-6* G281D dependent splicing remodeling upon infection ([Figure 3](#fig3){ref-type="fig"}), was also affected by *rnp-6* RNAi, whereas *gyg-1* had no detectable changes ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). Notably, *rnp-6* RNAi promoted the splicing of *prg-2* intron-1 ([Figure 4C](#fig4){ref-type="fig"}), which shows the same trend as seen during infection and is largely inhibited by the G281D mutation ([Figure 3B](#fig3){ref-type="fig"}). On the other hand, *rnp-6* RNAi increased the relative abundance of the longer isoform of *tos-1* ([Figure 4D](#fig4){ref-type="fig"}), which more resembles the change induced by the G281D mutation ([Figure 3D](#fig3){ref-type="fig"}). These results confirm that *rnp-6* modulates the splicing of infection induced alternatively spliced genes and indicate that *rnp-6* G281D substitution and *rnp-6* RNAi resulted in partially overlapping and partially different transcriptional and splicing responses (See Discussion). Furthermore, overexpressing RNP-6 greatly compromised infection survival upon *S. aureus* ([Figure 4E](#fig4){ref-type="fig"}) and *E. faecalis* exposure ([Figure 4---figure supplement 1E,F](#fig4s1){ref-type="fig"}), but promoted longevity at 25°C when the animals were cultured with the weakly pathogenic *E. coli* OP50 ([Figure 4F](#fig4){ref-type="fig"}). The sensitivity phenotype of the RNP-6 overexpressing strain is not due to differential bacterial exposure, since the phenotype was still manifest on full lawns ([Figure 4---figure supplement 1G](#fig4s1){ref-type="fig"}). Also, overexpression of RNP-6 did not have an observable effect on bacterial burden in *S. aureus* infected *C. elegans* ([Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}). Taken together, these results suggest that the activity of RNP-6 is detrimental to immunity and survival upon infection, but promotes longevity under non-infected conditions. Like the overexpressor, the G281D substitution is also immuno-suppressive and lifespan-extending, indicating that the substitution resembles a gain-of-function mutation in this context (see Discussion).

RNP-6 inhibits PMK-1 MAPK signaling {#s2-6}
-----------------------------------

We next sought to investigate mechanisms downstream of RNP-6. We used an online bioinformatic tool (<http://wormexp.zoologie.uni-kiel.de/wormexp/>) ([@bib53]) to investigate the similarity of the transcriptomic data of infection responses of the G281D mutant of *rnp-6*. Interestingly, we found that the *rnp-6* dependent infection responsive genes were significantly enriched for PMK-1 target genes ([Figure 5A](#fig5){ref-type="fig"}). Among the 116 RNP-6 dependent infection induced genes ([Figure 2C](#fig2){ref-type="fig"}), 17 were also PMK-1 dependent ([@bib4]; [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). For the 159 genes whose repression by infection was reverted by the *rnp-6* G281D substitution ([Figure 2D](#fig2){ref-type="fig"}), 55 of them were also up-regulated in the *pmk-1* deletion mutant ([@bib27]; [Figure 5---source data 2](#fig5sdata2){ref-type="supplementary-material"}). These results led us to hypothesize an involvement of PMK-1.

![RNP-6 controls PMK-1 activity.\
(**A**) Pie charts showing the portion of *rnp-6* dependent infection responsive genes which are also reported to be *pmk-1* dependent. 17 out of 116 *rnp-6* dependent infection induced genes also have *pmk-1* dependent induction (p\<0.0001). 55 out of 159 *rnp-6* dependent infection repressed genes are up-regulated in *pmk-1* deletion mutants (p\<0.0001). (**B,C**) Infection survival analysis. Wildtype, *pmk-1(km25)* and *tir-1(tm3036)* animals were fed with either control or *rnp-6* RNAi OP50 bacteria and then infected with *S. aureus. rnp-6* RNAi does not prolong survival in the *pmk-1* or *tir-1* deletion mutant (non-significant, log-rank test.). (**D**) Overexpression of RNP-6 does not further sensitize *pmk-1* deletion mutants to *S. aureus* infection (non-significant, log-rank test.). (**E**) *rnp-6(dh1127)* does not further sensitize the *pmk-1* deletion mutants to *S. aureus* infection (non-significant, log-rank test.). (**F**) *rnp-6(dh1127)* mutation decreases survival in wildtype background upon *P. aeruginosa* infection (p=0.0056, log-rank test). However, the double mutant of *rnp-6(dh1127)* and *pmk-1(km25)* has enhanced survival relative to *pmk-1(km25)* alone (p\<0.0001, log-rank test). (**G**) Western blot analysis showing the levels of phosphorylated PMK-1. N2 animals grown on HT115 RNAi bacteria targeting *rnp-6* possess higher levels of PMK-1 phosphorylation. \*\*p\<0.05. Error bars represent mean ± s.e.m., unpaired t-test. Survival experiments were performed three times independently.\
Figure 5---source data 1.List of *rnp-6* dependent infection induced genes with *pmk-1* dependency.\
Figure 5---source data 2.List of *rnp-6* dependent infection repressed genes with *pmk-1* dependency.](elife-57591-fig5){#fig5}

To test this hypothesis, we examined the genetic epistasis between *rnp-6* and *pmk-1*. Knocking down *rnp-6* increased the animals' survival upon *S. aureus* infection, and deletion of *pmk-1* or its upstream activator *tir-1* completely abolished the beneficial effect of *rnp-6* reduction ([Figure 5B,C](#fig5){ref-type="fig"}). By contrast, deletions of *daf-16/*FOXO or *hlh-30/*TFEB, which are also important regulators of innate immunity ([@bib15]; [@bib48]), had no and minimal effects on the *rnp-6* RNAi extended survival, respectively (53.6% increase in N2% and 43.4% increase in *hlh30(tm1978)*, area under survival curves) ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). Overexpressing RNP-6 or G281D substitution rendered the animals susceptible to *S. aureus* infection in wildtype background, but did not further enhance sensitivity in the *pmk-1* deletion background ([Figure 5D,E](#fig5){ref-type="fig"}). The *rnp-6* G281D substitution also did not further sensitize the *pmk-1* deletion mutant under *P. aeruginosa* infection conditions ([Figure 5F](#fig5){ref-type="fig"}). We conclude that the sensitivity caused by *rnp-6* G281D substitution or RNP-6 overexpression and *pmk-1* deletion are not additive, suggesting the two genes function in the same pathway to modulate infection survival.

PMK-1 becomes phosphorylated upon activation. Given the observed genetic interactions between *pmk-1* and *rnp-6*, we next sought to test whether RNP-6 affects the activity of PMK-1 by measuring phospho-PMK-1. Upon RNAi knockdown of *rnp-6*, we observed a significant increase in phospho-PMK-1 ([Figure 5G](#fig5){ref-type="fig"}), suggesting PMK-1 activity increases upon *rnp-6* reduction. This is consistent with the immuno-suppressive role of *rnp-6*. As our results imply that RNP-6 modulates PMK-1 MAPK signaling, we asked whether the splicing patterns of the genes involved in this pathway were affected by the *rnp-6* G281D mutation. However, we did not observe any reproducible difference in splicing patterns or expression levels of PMK-1 MAPK signaling components comparing wildtype and *rnp-6(dh1127)* animals under non-infected or *S. aureus* infected conditions ([Figure 5---figure supplement 2A--I](#fig5s2){ref-type="fig"}; [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"} and [2](#fig2sdata2){ref-type="supplementary-material"}), suggesting that *rnp-6* regulates this pathway via other mechanisms. Altogether, both genetic and biochemical analyses imply that RNP-6 exerts its inhibitory effects on immunity by suppressing the activity of PMK-1.

SFA-1 acts downstream of RNP-6 to restrain immunity and promote longevity {#s2-7}
-------------------------------------------------------------------------

Splicing has recently emerged as a determinant of animal lifespan ([@bib16]; [@bib41]). Since *rnp-6* promotes longevity ([Figures 1K](#fig1){ref-type="fig"} and [4F](#fig4){ref-type="fig"}) but compromises immunity ([Figure 4](#fig4){ref-type="fig"}), we suspected other lifespan promoting splicing factors may also inhibit immunity. Overexpressing splicing factor SFA-1 resulted in robust longevity under non-infected conditions ([Figure 6A](#fig6){ref-type="fig"}), as previously reported ([@bib16]). However, similar to *rnp-6*, SFA-1 overexpression severely compromised survival upon *S. aureus* ([Figure 6B](#fig6){ref-type="fig"}) and *E. faecalis* infection ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Moreover, RNAi knockdown of *sfa-1* not only increased infection survival in wildtype worms ([Figure 6C](#fig6){ref-type="fig"}), but also completely suppressed infection sensitivity of the G281D mutant of *rnp-6* ([Figure 6D](#fig6){ref-type="fig"}). Consistent with a strong interaction, SFA-1 overexpression did not further increase *rnp-6* G281D longevity when animals were cultured with *E. coli* OP50 ([Figure 6E](#fig6){ref-type="fig"}), and knocking down *sfa-1* completely suppressed *rnp-6* G281D longevity ([Figure 6F](#fig6){ref-type="fig"}). By contrast, knocking-down *repo-1*, which is also implicated in longevity ([@bib16]), only partially rescued the infection sensitivity caused by *rnp-6* G281D mutation ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), while *hrpu-1* knockdown had little effect ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}).

![Suppression of immunity by SFA-1.\
(**A**) Demographic analysis of lifespan. Overexpression of SFA-1 extends lifespan when the animals are cultured with*E. coli*OP50 at 25°C (p\<0.0001, log-rank test.). (**B**) Infection survival analysis. SFA-1 overexpressing animals show significant sensitivity to *S. aureus* infection (p=0.0165, log-rank test.). The *pmk-1* deletion mutant serves as a positive control for infection sensitivity. (**C**) Wildtype worms grown on control or *sfa-1* RNAi OP50 bacteria were infected with *S. aureus. sfa-1* knockdown improves survival (p=0.0048, log-rank test.). (**D**) *sfa-1* knockdown using OP50 RNAi bacteria suppresses infection sensitivity of *rnp-6(dh1127)* mutants (p\<0.0001, log-rank test, comparing *rnp-6(dh1127)* Control-i and *rnp-6 sfa-1i*). (**E**) Demographic analysis of lifespan. SFA-1 overexpression does not further extend the lifespan of *rnp-6(dh1127)* mutants. In fact, SFA-1 overexpression slightly reduces the *rnp-6* mutants' lifespan (p=0.0147, log-rank test.). (**F**) *sfa-1* RNAi (OP50) abolishes *rnp-6(dh1127)* longevity (p\<0.0001, log-rank test, comparing *rnp-6(dh1127)* Control-i and *rnp-6 sfa-1i*). (**G**) SFA-1 overexpression does not further sensitize *pmk-1(km25)* animals to *S. aureus* infection (non-significant, log-rank test.). (**H**) Western blot analysis showing the levels of phosphorylated PMK-1. N2 animals grown on OP50 RNAi bacteria targeting *sfa-1* possess higher levels of PMK-1 phosphorylation. Error bars represent mean ± s.e.m., \*p\<0.05, unpaired t-test. (**I**) Infection survival analysis. *sfa-1* knockdown using OP50 RNAi bacteria extends infection survival upon *S. aureus* infection in *pmk-1(km25)* mutants (p\<0.0001, log-rank test.). Experiments of panel A and E were performed twice. All other survival and lifespan experiments were performed three times independently.](elife-57591-fig6){#fig6}

Given the strong genetic interaction with SFA-1, we tested whether RNP-6 and SFA-1 physically interact in *C. elegans*. However, we saw no obvious co-immunoprecipitation of RNP-6 with SFA-1 ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). Thus, these factors probably function in structurally or temporally distinct steps during the splicing process. We also observed that the sensitivity caused by SFA-1 overexpression was not additive to that of *pmk-1* deletion ([Figure 6G](#fig6){ref-type="fig"}), supporting the idea of *sfa-1* and *pmk-1* working in the same pathway, similar to that of *rnp-6*. Next, we tested whether *sfa-1* also exerts inhibitory effects on PMK-1 activity. Knocking-down *sfa-1* also induced phosphorylation of PMK-1 ([Figure 6H](#fig6){ref-type="fig"}), indicating that *sfa-1* similarly restrains PMK-1 activation. In contrast to *rnp-6* RNAi, however, *sfa-1* RNAi was able to increase infection survival in *pmk-1* deletion mutants ([Figure 6I](#fig6){ref-type="fig"}), suggesting *sfa-1* also moderates immunity via *pmk-1* independent pathways. Taken together, these results point towards a similar suppression of immunity by both RNP-6 and SFA-1 through their modulation of the PMK-1 MAPK signaling pathway, with SFA-1 working downstream of RNP-6.

Mammalian PUF60 exerts immuno-suppressive and anti-inflammatory effects {#s2-8}
-----------------------------------------------------------------------

Because PUF60 is involved in various human diseases ([@bib40]; [@bib39]; [@bib52]), we next explored the potential role of *rnp-6* in imparting immunity in higher organisms. We first asked if PUF60, the mammalian homolog of *rnp-6*, is regulated during infection. We infected human epithelial HeLa cells, mouse embryonic fibroblasts (MEF) and RAW264.7 macrophage-like cells with *S. aureus* and observed a sharp reduction of PUF60 protein levels in all three cell types ([Figure 7A](#fig7){ref-type="fig"}). *S. aureus* infection also reduced PUF60 transcript levels ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). Therefore, mammalian PUF60 responds to infection by reducing its expression, while *C. elegans rnp-6* levels remain stable after infection ([Figure 1---figure supplement 1L,M](#fig1s1){ref-type="fig"}). Next, we wondered whether this reduction of PUF60 has an impact on the immune-response and utilized siRNA to reduce PUF60 expression in HeLa cells ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Interestingly, reduction of PUF60 alone was sufficient to drive expression of pro-inflammatory cytokines, namely IL-6, IL-8, CXCL2, IL-1α ([Figure 7B](#fig7){ref-type="fig"}), IL-18 and CCL5 ([Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}), but had no effects on anti-inflammatory gene TGF-β1 ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}). We also observed a moderate induction of the same cytokines upon PUF60 knockdown in RAW264.7 macrophage-like cells ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}) despite the relatively low RNAi efficiency of PUF60 in this cell line ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Similar results were observed in *C. elegans*, where RNAi against *rnp-6* also induced infection responsive genes ([Figure 4B](#fig4){ref-type="fig"}), indicating an evolutionarily conserved role of RNP-6/PUF60 of suppressing basal immune-gene expression.

![Evolutionary conservation of immuno-suppressive and anti-inflammatory functions of PUF60 in mammalian cells.\
(**A**) Western blot analysis of *S. aureus* infected HeLa, MEF and RAW264.7 cells at 6 hr post-infection. *S. aureus* infection significantly reduces the protein levels of PUF60. (**B**) qRT-PCR results. HeLa cells were transfected with either control non-targeting or PUF60 siRNA. The cells were harvested at post-transfection 48 hr. PUF60 RNAi induces cytokine expression. GAPDH was used for internal normalization. (**C**) qRT-PCR results of *S. aureus* infected HeLa cells. Cells were transfected with the indicated expression plasmids. At 48 hr post-transfection, the cells were infected with *S. aureus* and harvested at 6 hr post-infection. Transfection of the mutated PUF60 (G300D) plasmid significantly reduces the induction of pro-inflammatory cytokines. Although the trend of cytokine suppression is evident for wildtype PUF60, the effects do not reach statistical significance. RPL13A was used for internal normalization. (**D**) HeLa cells survival after *S. aureus* infection. Overexpression of either wildtype or the mutated PUF60 (G300D) improves cell survival at 24 hr post-infection. Cells were transfected with the indicated siRNA or expression plasmids and then infected with *S. aureus* 48 hr after transfection. Error bars represent mean ± s.e.m. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ns non-significant, unpaired t-test.](elife-57591-fig7){#fig7}

To further investigate the effects of PUF60 on cytokine expression, we constructed the mammalian version of the *C. elegans* gain of function G281D substitution. This glycine residue is conserved across evolution ([Figure 1D](#fig1){ref-type="fig"}) and corresponds to a G to D substitution at the 300^th^ amino acid in human PUF60. Equal amounts of the expression plasmids of wildtype and the mutated PUF60 were transfected into HeLa cells. The protein levels of the mutated PUF60 were lower compared to the wildtype form ([Figure 7---figure supplement 1G](#fig7s1){ref-type="fig"}), even though the expression levels of mRNA were similar ([Figure 7---figure supplement 1F](#fig7s1){ref-type="fig"}), suggesting the mutation may destabilize the protein. Intriguingly, overexpression of the mutated form of PUF60 stimulated expression of anti-inflammatory TGF-β1, while the wildtype PUF60 had no effects on TGF-β1 ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}). Furthermore, overexpression of the mutated PUF60 significantly reduced inflammation induced by *S. aureus* infection in HeLa cells. The induction of IL-8, IL-6, CXCL2 and IL-1α upon infection was significantly suppressed by overexpressing the mutated PUF60 ([Figure 7C](#fig7){ref-type="fig"}). Overexpression of wildtype PUF60 also exerted moderate inhibitory effects on cytokine induction but the effects were not statistically significant ([Figure 7C](#fig7){ref-type="fig"}). Also, overexpression of wildtype or the mutated form of PUF60 improved HeLa cell survival upon *S. aureus* infection at a later time point (post-infection 24 hr) ([Figure 7D](#fig7){ref-type="fig"}) without affecting bacterial internalization ([Figure 7---figure supplement 1H](#fig7s1){ref-type="fig"}). Enhanced survival might arise due to reduced inflammation mediated by PUF60. Remarkably then, the G281D mutation, originally identified in *C. elegans*, also works to enhance the immune-suppression of RNP-6/PUF60 in mammalian cells, and the function of RNP-6/PUF60 in suppressing immunity is highly conserved in evolution.

Discussion {#s3}
==========

Our data reveal that the splicing factor RNP-6/PUF60 is a novel regulator of immunity and lifespan. Viruses commonly interact with the host splicing machinery, whereas not much is known regarding bacterial interference with host RNA splicing ([@bib7]). We provide evidence that in *C. elegans*, bacterial infections affect mRNA splicing, and perturbations of splicing is a trigger for immune responses while, by inference, increased splicing activity compromises immunity, thus providing a new explanation for how immune responses are modulated in the worms. Importantly, the function of RNP-6/PUF60 in immunity is conserved in mammalian cells. Thus, our results also shed light on the mechanisms of human diseases that involve PUF60.

Long-lived animals are often more stress resistant. Stress resistance and longevity are thought to be tightly and positively correlated, but this idea has been recently disputed ([@bib2]). The behavior of splicing factors RNP-6 and SFA-1 is another clear example of disconnecting longevity and biotic stress resistance. The *rnp-6* G281D substitution and overexpression of splicing factors (RNP-6 and SFA-1) lead to sensitivity to infection but promote longevity. Notably, the *rnp-6* G281D mutant is resistant to abiotic stresses, suggesting the sensitivity towards infection is mediated by specialized mechanisms rather than a general decline of fitness in this mutant.

One question that remains to be investigated is the nature of the *rnp-6* G281D mutation. In the context of survival, phenotypically this mutation appears to be a gain of function as both the G281D substitution and RNP-6 over-expression lead to compromised infection survival but prolonged lifespan on OP50. However, the G281D substitution also shows characteristics of a loss of function mutation in other aspects. For example, the transcriptional and splicing changes induced by the G281D substitution are complex with some genes showing patterns similar to that of *rnp-6* RNAi while others having different patterns. We believe that the G281D substitution does not simply increase or decrease the activity of RNP-6 but rather causes a complex change in the affinity of the RNA binding domain to different RNA molecules. The location of the substitution in the RNA binding motif also supports this idea.

One limitation of the splicing assaying with PCR on RNA extracted from whole *C. elegans* animals is that the changes observed might be due to changes in isoform expression pattern in different tissues rather than alternate splicing within the same tissue, as genes can have tissue enriched isoforms. Nevertheless, the *rnp-6* dependence of these splicing changes argues in favor of a true splicing effect.

In mammals, PUF60 is also known as far-upstream element binding protein, which inhibits the transcriptional factor FUSE binding protein ([@bib11]). Although RNP-6 clearly affects the transcriptome, whether a specific transcriptional regulatory function of RNP-6/PUF60 plays a role in immunity is unclear. Often transcriptional changes can reflect the coupling of transcriptional and splicing events ([@bib3]). In addition, the results from SFA-1 suggest that the effects of RNP-6 on immunity are dependent on the splicing machinery, arguing against a sole involvement of the transcriptional regulatory function of RNP-6/PUF60.

Our data demonstrate that PMK-1 MAPK signaling falls under the control of the splicing machinery. How MAPK signaling is activated in *C. elegans* is not fully understood ([@bib20]). The current study suggests splicing is an important modulator of MAPK signaling and likely works upstream of TIR-1/SARM. In the non-infected state, splicing factors suppress immunity, but during bacterial infections, splicing is perturbed, leading to the activation of immune responses. Interestingly, our bioinformatic analysis suggests splicing changes upon infection are not global but limited, suggesting specificity. How altering splicing can lead to activation of PMK-1 and immune responses is not well-understood at this point. Splicing is a core cellular process and perturbations of other cellular processes, such as mitochondrial or nucleolar functions, have been shown to activate immunity ([@bib26]; [@bib44]). Thus, *rnp-6*/PUF60 RNAi derepression of the immune response could reflect damage mediated immunity. On the other hand, *rnp-6* G281D substitution and overexpression exhibit an immunosuppressive function, arguing for a more novel and specific role of splicing in the regulation of immune defense.

In support of the latter idea, MyD88, a Toll-like-receptor signaling adaptor and an analog (functionally similar but differ significantly at the sequence level) of *tir-1* in mammals, is controlled by alternative mRNA splicing ([@bib10]). Unlike the situation in mammalian cells, however, we did not observe any significant changes of *tir-1* splicing upon infection or *rnp-6* G281D substitution, nor of other MAPK signaling components. Conceivably other means to regulate *tir-1* are at play. Splicing acts downstream of dietary restriction to promote longevity ([@bib16]). Aberrant activation of PMK-1 causes toxicity and shorter lifespan in *C. elegans* ([@bib8]). Also, in both dietary restricted animals and *daf-2* mutants, PMK-1 MAPK signaling is inhibited ([@bib51]). One attractive hypothesis is that longevity promoting interventions extend lifespan by suppressing MAPK signaling through splicing.

Our study also reveals a novel and evolutionarily conserved function of RNP-6/PUF60 in regulating immunity in mammalian cells. Although *rnp-6* levels remain stable after infection in *C. elegans*, infection reduces the abundance of PUF60 in various mammalian cells. We hypothesize that infection induced down-regulation of PUF60 might be a recent evolutionary adaptation of the immune system. Alternatively, the activities of RNP-6 may be regulated in *C. elegans* by other ways without affecting its abundance. Indeed, infection induced splicing remodeling is dependent on RNP-6, and knocking-down *rnp-6* affects splicing of genes whose splicing is regulated by infection, suggesting that RNP-6 activity is influenced by infection. Reduction of PUF60 by RNAi is sufficient to induce pro-inflammatory cytokine expression, suggesting that PUF60 reduction induced by bacterial infection is a trigger of inflammation. This intriguing observation raises the question of how perturbation of splicing can activate immune responses. One potential explanation is aberrant splicing may produce immuno-stimulatory RNAs which can be detected by nucleic acid sensing PRRs, such as RIG-I ([@bib54]), cGAS/STING ([@bib24]; [@bib38]) and PKR ([@bib13]; [@bib31]). Overexpression of PUF60, especially the mutated form, is able to reduce inflammation induced by *S. aureus* infection. The G281D mutation, which we identified in *C. elegans,* analogously augments the immunosuppressing activity of PUF60. These results indicate that the RNA binding motif where the mutation resides plays a crucial role in the control of immunity, probably through interacting with some unknown RNA species. Though both RNP-6 and PUF60 apparently suppress the immune response, the outcomes for survival upon pathogen challenge are different. This may reflect how the balance of proinflammatory and anti-inflammatory molecules ultimately affect survival in different contexts. The E3 ubiquitin ligase ipaH9.8 from *Shigella* was reported to bind another splicing factor U2AF35 and modulate host cytokine production ([@bib30]). Whether PUF60 is also targeted by bacterial factors remains to be investigated.

Hypomorphic mutations of PUF60 are known to cause a rare genetic disease called Verheij syndrome ([@bib1]; [@bib12]; [@bib47]; [@bib52]). Our results suggest a reduction of PUF60 activity may trigger inflammation, which could be one of the drivers of the pathology. Further examinations on the patient samples are needed to test this interesting possibility. PUF60 is also implicated in HBV infection ([@bib39]) and breast cancer ([@bib40]). Whether PUF60 mediated immune regulation plays a role in these diseases awaits investigation. Targeting host splicing can also be an alternative therapeutic approach to antibiotic and multidrug resistant bacterial infection.

Our study paves the way to further explore the intriguing connection between splicing, lifespan and innate immunity in an evolutionarily conserved context. We propose that splicing factors might mediate a tradeoff between immunity and longevity, and further postulate that longevity could have arisen in some species by limiting inflammatory processes. Our results also raise multiple fundamental questions. How do the splicing factors RNP-6 and SFA-1 work to promote longevity, but compromise survival upon bacterial infection? Does RNP-6/PUF60 regulate immunity by interacting with RNA, and if yes, which RNA(s) is/are involved? How does the G281D mutation change the molecular functions of RNP-6/PUF60? Further studies are needed to precisely elucidate how splicing affects host responses towards infection.

Materials and methods {#s4}
=====================

Experimental organism- *C. elegans* {#s4-1}
-----------------------------------

The following strains were used in this study: N2 (wildtype), *rnp-6(dh1124), rnp-6(dh1125), rnp-6(dh1127), hlh-30(tm1978), rnp-6(dh1188), rnp-6(dh1127); wbmEx340\[eft-3p::3xFLAG::sfa-1 cDNA::unc-54 3\'UTR\]; \[myo-3p::mCherry::unc-54 3\'UTR\], dhEx1132\[rnp-6p::rnp-6; myo-2p::GFP\]* (RNP-6 OE\#1)*, dhEx1133\[rnp-6p::rnp-6; myo-2p::GFP\]* (RNP-6 OE\#2)*, dhEx1134\[rnp-6p::rnp-6; myo-2p::GFP\]* (RNP-6 OE\#3)*, pmk-1(km25), tir-1(tm3036), pmk-1(km25); dhEx1132\[rnp-6p::rnp-6; myo-2p::GFP\], rnp-6(dh1127); pmk-1(km25), daf-16(mu86), wbmEx340\[eft-3p::3xFLAG::sfa-1 cDNA::unc-54 3\'UTR\]; \[myo-3p::mCherry::unc-54 3\'UTR\], rnp-6(dh1188); wbmEx340\[eft-3p::3xFLAG::sfa-1 cDNA::unc-54 3\'UTR\]; \[myo-3p::mCherry::unc-54 3\'UTR\]* and *pmk-1(km25); wbmEx340\[eft-3p::3xFLAG::sfa-1 cDNA::unc-54 3\'UTR\]; \[myo-3p::mCherry::unc-54 3\'UTR\].* The animals were maintained at 20°C following standard procedures ([@bib6]). For all experiments, synchronization of the animals was done using the egg laying method.

Experimental organism- Mammalian cell culture {#s4-2}
---------------------------------------------

HeLa and MEF cells were obtained from ATCC. RAW264.7 cells were obtained from ECACC. The cells were cultured at 37°C with 5% carbon dioxide in a humid atmosphere. Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) was used as the culturing medium. The cells were tested and are negative for mycoplasma contamination.

Experimental organism- Bacteria {#s4-3}
-------------------------------

*Staphylococcus aureus* (strain MW2), *Enterococcus faecalis* (strain ATCC 29212), *Pseudomonas aeruginosa* (strain PA14) and *Escherichia coli* (strain OP50, HT115 and OP50 xu363) were used in this study. Bacteria were maintained in glycerol stocks at −80°C. When needed, bacteria were streaked out on appropriate agar plates. Tryptic soy agar (TSA) plates for *S. aureus*, brain heart infusion (BHI) plates for *E. faecalis* and lysogeny broth (LB) plates for *P. aeruginosa* and *E. coli*. Colonies were picked into designated growth medium. *S. aureus* was grown in tryptic soy broth (TSB) medium. *E. faecalis* was grown in BHI medium. *P. aeruginosa* and*E. coli*were grown in LB medium. 100 μg/mL of ampicillin was supplemented to the plates and cultures of *Escherichia coli* (strain HT115 and OP50 xu363) to maintain the plasmids for RNAi feeding experiments.

Genome sequencing and genetic mapping {#s4-4}
-------------------------------------

The cold resistant mutants were crossed with Hawaiian CB4856 males. Young adults of the F2 generation were exposed to cold stress, and the survivors were singled and propagated on standard nematode growth medium (NGM) plates seeded with *E. coli* OP50. The cold resistant segregants were then pooled together, and genomic DNA were purified using Gentra Puregene Kit (Qiagen). The pooled DNA was sequenced on an Illumina HiSeq platform (paired-end 150 nucleotide). MiModD software (<http://www.celegans.de/en/mimodd>) was used to locate the mutations.

*C. elegans* abiotic stress resistance assays {#s4-5}
---------------------------------------------

For all stress assays, synchronized young adult hermaphrodites were used. For cold resistance, worms were incubated at 2°C on standard NGM plates with OP50 for the indicated time. The animals were then allowed to recovered at 20°C for 12--24 hr. After that, their survival was score. For heat resistance, animals on standard NGM plates seeded with OP50 were transferred to 35°C. Survival was monitored every hour. For oxidation stress, worms were placed on NGM plates with OP50 supplemented with 20 mM paraquat. Survival was monitored every 12 hr. Animals that did not respond to gentle touch by a worm pick were interpreted as dead.

*C. elegans* infection survival experiments {#s4-6}
-------------------------------------------

*S. aureus* (Strain MW2), *E. faecalis* (Strain ATCC 29212) and *P. aeruginosa* (Strain PA14) were grown in the appropriate medium at 37°C with gentle shaking overnight. 20 μl of the overnight bacterial cultures was seeded at the center of the relevant agar plates, TSA plates with 10 μg/mL nalidixic acid (NAL) for *S. aureus*, BHI plates with 10 μg/mL NAL for *E. faecalis* and modified NGM (Peptone content 3.5 g/L instead of 2.5 g/L), for *P. aeruginosa*. For full lawn experiments, 100 μl of the bacterial culture was seeded and spread all over the surface of the agar plate. The seeded killing assay plates were allowed to grow overnight at 37°C. On the next day, the plates were left at room temperature for at least 6 hr before the infection experiments. Around 25 synchronized young adult worms were transferred to the plates. three technical replicate plates were set up for each condition. The plates were then incubated at 25°C unless specifically stated. Scoring was performed every 24 hr for *E. faecalis* or every 12 hr for *S. aureus* and *P. aeruginosa*. Worms were scored as dead if the animals did not respond to gentle touch by a worm pick. Worms that crawled off the plates or had ruptured vulva phenotypes were censored from the analysis. All *C. elegans* killing assays were performed three times independently unless otherwise stated. Genotypes were concealed for all *C. elegans* infection survival experiments in order to eliminate any investigator-induced bias. Results of each biological replicate of infection survival and lifespan experiments can be found in [Supplementary file 6](#supp6){ref-type="supplementary-material"}.

Chemical sterilization of *C. elegans* animals {#s4-7}
----------------------------------------------

Animals were sterilized with treatment of 5-Fluoro-2\'-deoxyuridine (FUDR). L4 animals were incubated on NGM plates with OP50 and 50 μg/mL of FUDR supplementation at 20°C for 18--24 hr.

Colony Forming Unit (CFU) Assay in *C. elegans* {#s4-8}
-----------------------------------------------

Chemically sterilized young adults were infected with full lawn *S. aureus* plates for 24 hr. 10 animals were harvested for each genotype. The animals were washed three times with ice cold M9 buffer with 0.1% trion X-100. After washing, the worms were resuspended in 300 μl M9 buffer with 0.1% trion X-100. An aliquot of the buffer was plated on NAL containing TSA plates to quantify external bacterial counts. Animals were then homogenized by a motor-driven pestle grinder. The homogenates were diluted and plated on NAL containing TSA plates. CFU from the pre-homogenized samples were subtracted from the CFU value after homogenization to calculate the CFU per animal values.

Lifespan assay {#s4-9}
--------------

Worms were allowed to grow to young adult stage at 20°C on standard NGM plates with OP50. For each genotype, 120 young adults were then transferred to NGM plates with OP50 supplemented with 10 μM of FUDR. The cultures were continued at either 20°C or 25°C. Survival was monitored at least three times per week. Worms which did not respond to gentle touch by a worm pick were scored as dead and were removed from the plates. Animals that crawled off the plate or have ruptured vulva phenotypes were censored. All lifespan experiments were done three times independently unless otherwise stated. Genotypes were concealed during the lifespan experiments in order to eliminate any investigator-induced bias.

*C. elegans* sample preparation for RNA analysis {#s4-10}
------------------------------------------------

*C. elegans* samples used for PCRs and RNA sequencing were prepared in the following way. Animals were allowed to grow at 20°C on NGM plates seeded with OP50 to age synchronized young adults. After washing with M9 buffer, they were transferred to 10 cm TSA plates supplemented with 10 μg/mL NAL carrying either *S. aureus* or heat-inactivated OP50 bacteria. TSA plates with heat-inactivated OP50 serve as the non-infection control here. The *E. coli* culture was concentrated 10 times before seeding on the plates. 500 μl of *S. aureus* or heat-inactivated E. coli OP50 were spread on the TSA plates, which were then incubated at 37°C for 6 hr. *C. elegans* worms were then transferred to the plates after the plates had equilibrated to room temperature. The animals were incubated on the plates at 25°C. After 4 hr of infection, the worms were washed with M9 buffer for two times before lysis with QIAzol Lysis Reagent (Qiagen).

RNA extraction and cDNA synthesis {#s4-11}
---------------------------------

*C. elegans* and mammalian cells were lyzed with QIAzol Lysis Reagent. RNA was extracted using chloroform extraction method. The samples were then purified using RNeasy Mini Kit (Qiagen). Purity and concentration of the RNA samples were assessed using a NanoDrop 2000c (peqLab) equipment. cDNA synthesis was performed using iScript cDNA synthesis kit (Bio-Rad). Standard protocols provided by the manufacturers were followed for all mentioned commercial kits.

Alternative splicing PCR assay {#s4-12}
------------------------------

DreamTaq DNA Polymerases (ThermoFisher) was used to amplify the *prg-2, gyg-1 and tos-1* segments. The primer design for *tos-1* is based on a recent publication ([@bib23]). PCR reactions were cycled for 35 cycles with annealing temperature of 57°C. The products were visualized by staining with Roti-GelStain (Carl Roth) after agarose gel electrophoresis. For primer sequences, please refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Quantitative PCR (qPCR) {#s4-13}
-----------------------

Power SYBR Green master mix (Applied Biosystems) was used for qPCR experiments. A JANUS automated workstation (PerkinElmer) was used for pipetting the reagents and cDNA samples into a 384 well plate. Thermal cycling was performed using a ViiA7 384 Real- Time PCR System machine (Applied Biosystems). *snb-1* was used for internal normalization for *C. elegans* targets. GAPDH or RPL13A were used for internal normalization for human targets. GAPDH was used for internal normalization of mouse targets. Relative expression levels were calculated using the comparative CT method. Special attention was paid to ensure that the primer sets detect all annotated isoforms. For primer sequences and binding locations, please refer to [Supplementary file 1](#supp1){ref-type="supplementary-material"}, [2](#supp2){ref-type="supplementary-material"}, [3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}.

Transcriptomic profiling and bioinformatic analysis {#s4-14}
---------------------------------------------------

1 μg of total RNA was used per sample for library preparation. We used the protocol of Illumina TruSeq stranded RiboZero. After purification and validation (2200 TapeStation; Agilent Technologies), total of 12 libraries (non-infected N2, non-infected *rnp-6(dh1127)*, infected N2 and infected *rnp-6(dh1127)* in each biological replicate, three biological replicates in total) were pooled for quantification using the KAPA Library Quantification kit (Peqlab) and the 7900HT Sequence Detection System (Applied Biosystems). The libraries were then sequenced on one lane of an Illumina HiSeq4000 sequencing system using a paired end 2 × 75 nt sequencing protocol. For data analysis, Wormbase genome (WBcel235_89) was used for alignment of the reads. This was performed with the Hisat version 2.0.4 software. Differentially expressed genes (DEGs) (q-value \<0.05) between different samples were identified using the stringtie version 1.3.0, followed by Cufflinks version 2.2. The DAVID (Database for Annotation, Visualization and Integrated Discovery) database was used for enrichment and Gene Ontology (GO) analysis. Cufflinks, KISSDE and SAJR were used for the splicing analysis. q value/p adjusted \<0.05 is considered to be significant.

Protein sample preparation and western blotting {#s4-15}
-----------------------------------------------

For *C. elegans* samples, two different methods were employed. Animals were picked into ice-cooled M9 buffer. 6X Laemmli lysis buffer with 5% 2-mercaptoethanol was then added to the mixture, which was then frozen in liquid nitrogen immediately. Alternatively, animals were first washed with M9 buffer. The worm pellets were resuspended in RIPA buffer supplemented with cOmplete Protease Inhibitor (Roche) and PhosSTOP (Roche) and snap frozen in liquid nitrogen. The thawed samples were lyzed using Bioruptor Sonication System (Diagenode). For mammalian cell samples, the cells were first washed with PBS and then lyzed with RIPA buffer supplemented with cOmplete Protease Inhibitor (Roche) and PhosSTOP (Roche). Cell debris was removed by centrifugation. Protein concentration was estimated using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Protein samples were then heated to 95°C for 10 min in Laemmli buffer with 0.8% 2-mercaptoethanol in order to denature the proteins. The samples were sonicated in a sonicating water bath for 10 min if there is excessive DNA, which obscures the subsequent loading process. Samples were loaded on 4--15% MiniPROTEAN TGXTM Precast Protein Gels (Bio-Rad), and electrophoresis was performed at constant voltage of 200V for around 40 min. After separation, the proteins were transferred to PVDF membranes using Trans-Blot TurboTM Transfer System (BioRad). 5% Bovine serum albumin (BSA) or 5% milk in Tris-buffered Saline and Tween20 (TBST) were used for blocking of the membranes. After antibody incubations and washing with TBST buffer, imaging of the membranes was performed with ChemiDoc Imager (BioRad). Western Lightning Plus Enhanced Chemiluminescence Substrate (PerkinElmer) was used as the chemiluminescence reagent. A list of antibodies is provided in [Supplementary file 5](#supp5){ref-type="supplementary-material"}.

Co-immunoprecipitation {#s4-16}
----------------------

Worms expressing HA::RNP-6, FLAG-SFA-1 or both were harvested, and proteins were extracted using the Bioruptor method. We used buffer containing 0.5% NP40, 150 mM NaCL and 50 mM Tris pH 7.4 supplemented with cOmplete Protease Inhibitor (Roche) and PhosSTOP (Roche) for immunoprecipitation. Flag immunoprecipitation was performed using Dynabeads Protein G (ThermoFisher Scientific) and FLAG M2 mouse monoclonal antibody (Sigma), following manufacturer's protocols. Proteins were eluted from the beads by boiling with Laemmli buffer.

RNAi in *C. elegans* {#s4-17}
--------------------

Two different strains of RNAi competent bacterial strains were used in this study, namely *E. coli* HT115 and *E. coli* OP50 xu363. The HT115 bacteria were from the Vidal or Ahringer library. OP50 xu363 bacteria were transformed with dsRNA expression plasmids, which were extracted from the respective HT115 bacterial strains. The bacteria were grown in LB medium supplemented 100 μg/mL ampicillin at 37°C overnight with gentle shaking. The culture was spread on RNAi plates, which are NGM plates with addition of 100 μg/mL ampicillin and 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The RNAi bacteria were allowed to grow on the plates at room temperature for at least 12 hr. RNAi was initiated by letting the animals to feed on the desired RNAi bacteria. For infection survival experiments, *rnp-6* RNAi was initiated around 30 hr before infection in order to prevent developmental abnormalities.

Transfection of mammalian cells {#s4-18}
-------------------------------

siRNA against PUF60 and non-targeting siRNA were purchased from Dharmacon (GE Healthcare Life Sciences). Lipofectamine 3000 (ThermoFisher Scientific) was used as the transfection reagent for both siRNA and plasmids in HeLa cells. Lipofectamine RNAiMAX was used for siRNA transfections in RAW264.7 cells. For all transfection experiments, we followed the manufacturers' protocols.

Infection of mammalian cells {#s4-19}
----------------------------

*S. aureus* (MW2) was used for infection at multiplicity of infection (MOI) 100. Late logarithmic phase grown bacterial *S. aureus* cultures were diluted in DMEM with 10% FCS to the designated MOI. Cells were washed with PBS and then incubated with the bacterial suspension for 10 min at room temperature and another 30 min at 37°C with 5% CO~2~ in a humid atmosphere to allow internalization of the bacteria. After that, the infection medium was removed, and the residual extracellular bacteria were removed by washing with PBS and incubation with DMEM medium with 10% FCS and 50 μg/ml gentamicin for 1 hr. Lower concentration of gentamicin (10 μg/ml) was used for continued culture after the initial 1 hr incubation.

To quantify the internalized bacteria, the cells were lyzed with PBS containing 0.3% of Triton X-100 at room temperature for 5 min to release intracellular bacteria. Amounts of bacteria were determined by serial dilution and plating on TSA plates.

Cell viability was assayed by trypan blue exclusion method. At the indicated time points, infected HeLa cells were first washed with PBS to remove any dead cells in suspension. The cells were then dissociated by incubation with 0.5% trypsin. Cells were then mixed with trypan blue solution. Live cells which do not uptake trypan blue were counted using a hemocytometer.

Materials availability {#s4-20}
----------------------

Requests for reagents, *C. elegans* strains, or any other resources should be directed to and will be fulfilled by the Lead Contact, Adam Antebi (Aantebi\@age.mpg.de).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The authors identified a splicing factor RNP-6/PUF60 whose activity suppresses immunity, but also promotes longevity, suggesting a trade-off between these two processes. The authors reveal the role of specific components of the splicing machinery in the modulation of immunity, which is important because the role of splicing in immunity is still poorly characterized. The merit of this article is that it illuminates a novel aspect of innate immune regulation in the nematode *Caenorhabditis elegans* that might be conserved in other animals.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"Evolutionarily Conserved Regulation of Immunity by the Splicing Factor RNP-6/PUF60\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Orane Visvikis (Reviewer \#1).

Our decision has been reached after consultation between the reviewers. As you can see from the comments, the reviewers were rather positive about the manuscript and the possibility to publish it in *eLife*. Nevertheless, they feel that there are too many requested work to allow a revision in two months. The consensus was therefore to reject the paper but to allow resubmission. If you decide to submit a revised version, it will be considered as a new submission but will likely be treated by the same reviewers. The decision \'Reject but allowing resubmission\' gives you more time to revise the manuscript. We therefore encourage you to submit a new revised version of your manuscript that carefully addresses the point raised by the reviewers. If you feel that you cannot address the reviewer\'s comments, it is also possible to transfer the manuscript to another journal.

Reviewer \#1:

In this article, Kew et al. have used *C. elegans* model and mammalian cell lines to elegantly unravel the evolutionary conserved immune function of the splicing factor RNP6/PUF60. By combining numerous and complementary approaches (genetic screen, CRISPR gene editing, RNA-sequencing, in vivo survival assays, molecular and biochemical analysis), the authors provide strong evidence of the repressive immune function of RNP-6/PUF60 in *C. elegans*, relying both on control of RNA splicing and gene expression, the latter lying upstream the *pmk-1*/p38 pathway. They also provide evidence that another splicing factor, namely SFA-1, work with RNP-6 to mediate host defense, underlying the importance of the RNA splicing function innate immunity. Finally, they show that PUF60 expression is repressed during infection of mammalian cell lines, which increases pro-inflammatory cytokines expression and promotes survival of infected cells. Overall, this well-conducted study reveals a novel function of PUF60 and contribute to enlarge the knowledge of a field in expansion. I would recommend this article for publication in *eLife*.

1\) A major concern of this study relays on how survival assay were performed (partial or full lawn) which is not clear and may be of critical importance for the conclusion. Figure 4A: this survival assay testing *rnp-6* RNAi was apparently performed using plates with partial lawn of *S. aureus* as the authors state to confirm this result with a survival assay using full lawn plates (subsection "The activity of RNP-6 impairs immunity"). Is the survival assay with partial lawn of *S. aureus* their standard assay ? This need to be clarified in the next and in the Materials and methods. Indeed, it is not clear how the experiments with *rnp-6(dh1127)* and *rnp-6(dh1125)* in Figure 1H (as well as in Figure 1I-J with other pathogens) and Figure 1---figure supplement 1I, J and K, or with the overexpressing OE strains (Figure 4D) were performed. Indeed, if based on the full lawn assay, the authors can conclude that the *rnp-6* RNAi phenotype, which display extend survival compared to control, is not a difference in bacterial exposure, it is not clear whether the phenotypes of rpn-6 G281D mutants or of the OE strains, which display enhanced susceptibility to pathogens (Esp) compared to control, are due to reduced immune response or reduced aversive behavior (and increased bacterial exposure) compared to N2. Full lawn experiment should be performed in order to conclude on the immune role of *rnp-6*. If partial lawn have been performed, the authors need to compare the bacterial lawn occupancy of RNP-6D281R mutants and the OE strains with N2. The author will be able to conclude on the immune regulatory function of RNP-6 only if RNP-6D281R mutant and N2 have the same avoidance behavior (and been exposed in a similar way to *S. aureus*).

2\) As a splicing factor, rpn-6 affects RNA splicing. I believe it would improve the manuscript to specify how primer pairs have been designed so that qPCR experiments reveal an actual change in gene expression and not a change in RNA splicing (Figure 2A).

3\) Figure 5GH and Figure 6H: condition of these experiments are rather surprising. While most of the *pmk-1* and *rnp-6* genetic experiment are made in animals infected by *S. aureus*, the authors analyze the effect RNP6 on PMK-1 phosphorylation either in resting condition (RNAi) or during infection by *P. aeruginosa*. It would greatly increase the quality of the conclusions to show 1) the level of P-PMK1 in N2i and *rnp-6i* animals infected by *S. aureus*; 2) the level of P-PMK1 in N2, *rnp-6(dh1127)* and RNP6 OE strain in the context of *S. aureus* infection. In addition, if anti-pmk1 (Kim et al., 2002) can be obtained, it would be good to blot total *pmk-1* to robustly show that variation of P-*pmk-1* are really changes in signaling rather a change in total *pmk-1* protein level.

4\) I believe the author should cite the work of the Sasakawa group (Okuda et al., 2005) who had previously identified the Shigella NEL effector IpaH9.8 to bind RNA splicing factor U2AF35 to modulate host immune response. Although IpaH9.8 had later been shown to also target NEMO to control NF-κB and host immune response (Ashida et al. Nat Cell Biol 2010), it was shown that U2AF35 siRNA treatment reduces pro-inflammatory cytokines in Shigella-infected cells HeLa (Okuda et al., 2005). Although this paper show opposite results in term of cytokine expression, it is a first evidence that modulation of a splicing factor, which is related to PUF60, during bacterial infection impacts immune responses, which reinforce the findings of Kew et al.

Reviewer \#2:

This is a very solid investigation of how splicing factors influence stress and longevity signaling in *C. elegans* that include experiments showing similar interactions in human cells. The role of RNA splicing in stress responses of animal cells is poorly studied. This study identifies a conserved RNA binding protein that plays important roles in stress responses of *C. elegans* and human cells. Precise molecular mechanism have not been revealed, but the role of *rnp-6* and splicing in immune response are convincingly demonstrated. Furthermore, the experiments are well conceived and reported. The genetic controls are particularly robust.

1\) Stress survival and longevity data -- These assays can be notoriously variable between trials. Therefore, reporting of data from at least three independent trials is customary for these types of studies. The comparisons should be analyzes as individual trials as well as combined. These data can be provided in supporting files.

2\) I have concerns over the use of the *ret-1* reporter system. It appears that the GFP and RFP are largely expressed is different tissues (head and intestine, respectively) and that the changes in ratio are largely attributed to changes in only GFP versus a true shift from one to the other. The authors should include data for changes in GFP and RFP in addition to the rations. Furthermore, controls for total expression of the reporter would be needed to be sure that these effects are not a reflection of changes in total expression in certain tissues, versus a true shift in splicing within common tissues.

3\) Figures 5G-H and 6H -- quantification of the representative data for Figure 5H is missing. Also, it is customary to include blots for total PMK-1 to determine if the effects are at the total level or protein modification level.

Reviewer \#3:

Kew et al. investigate the link between splicing and the immunity and longevity in *C. elegans* and extend their study to a mammalian cell culture model. Because of my expertise, I restrict my comments on the experiments to those using *C. elegans*.

1\) While the results are intriguing and would be of broad interest, I was concerned by Figure 3F, as in the infected sample, there are clearly larvae hatched inside that have a high GFP level and low mCherry level. This is a real problem. It indicates that (i) the experiments are not properly conducted (ii) the results involving differential splicing could be a result of differences that exist between different stages. Even if the worms shown were exceptional, it is notable that a significant number of the 83 genes alternatively spliced upon *S. aureus* infection in wildtype animals are associated with aldicarb resistance. As alternative splicing is tissue as well as stage specific (e.g. neuron-specific isoforms for many genes), this raises the possibility that the results are due to a differential effect of infection on transcription in a single tissue (including through a general effect on cell viability or developmental speed). The same applies for the effect seen in the *rnp-6* mutant; changes in transcription within one tissue, or even subtle changes in developmental stage, would give the same result as alterations in splicing across tissues in an age-synchronized population.

2\) Given the apparent strong effect on the ret reporter, which presumably should reflect endogenous splicing patterns, how is it that *ret-1* was not identified in the sequencing-based analysis? It is unfortunate that the authors did not generated this type of reporter for at least one of the genes they identified as undergoing differential splicing.

3\) Figure 5---figure supplement 1 shows sequencing reads coverage for several genes. If the figure is only matching pairs for their paired end 2x75nt sequencing, which it should be for this type of analysis, the level of intronic signal for several genes is unexpected. So, when they write, \"The splicing patterns of these genes are not significantly affected by *S. aureus* infection or the *rnp-6* G281D mutation\", what is the criterion for \"significant\", especially if one looks at the last example, *cebp-1*, for which there is a stark difference regarding retention of the last intron between wild-type and *rnp-6* samples. \[typo: *S. aurues* in figure\]. This is particularly relevant given the known links between *cebp-1*, its 3\' UTR (pubmed/28673818), *pmk-1* (pubmed/27927209) and innate immunity.

4\) To understand the basis of altered resistance, it is standard in the field to perform simple tests to assay the extent of bacterial colonization.

5\) Interpretation of Figure 2E is complicated by the fact that the constitutive expression level of at least one of the genes under study differs between wild-type and mutant worms. Thus, for *nlp-30*, there is the same fold-change after infection in mutant and wild-type, so the induction is not *rnp-6* dependent. One therefore wonders whether their strategy for gene selection (Figure 2C) is entirely appropriate.

\[Editors' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for submitting your article \"Evolutionarily conserved regulation of immunity by the splicing factor RNP-6/PUF60\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Orane Visvikis (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is \"in revision at *eLife*\". Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)

Summary:

The authors identified a splicing factor RNP-6/PUF60 whose activity suppresses immunity, but promotes longevity, suggesting a trade-off between these two processes. The authors reveal the role of specific components of the splicing machinery in the modulation of immunity, which is important because the role of splicing in immunity is still poorly characterized. The merit of this article is that it illuminates a novel aspect of innate immune regulation in the nematode *Caenorhabditis elegans* that might be conserved in other animals.

Essential revisions:

1\) Despite the additional data provided, it is still not clear how RNP-6 impacts the PMK-1 pathway during *S. aureus* and *P. aeruginosa* infection. \"RNP-6 exerts its inhibitory effects on immunity by suppressing the activity of PMK-1\" (L 305-306) is over-stated as the authors do not have proof that *rnp-6* impact the activation (phosphorylation) of PMK-1 during infection. Indeed:

-- The authors find no effect of *rnp-6* OE strain or *rnp-6* G281D mutant on the phospho-level of PMK-1 during *S. aureus* infection (rebuttal experiment).

-- The authors state that *rnp-6* RNAi reduces P-PMK-1 during *S. aureus* infection, but this result is rather questionable considering the western-blot shown (rebuttal). There are huge differences in total protein levels as revealed by the loading control (actin), but these differences are not as strong in total PMK-1. This either suggest that 1) that the level of total PMK-1 varies, or 2) the experiment is not well conducted.

-- Figure 5---figure supplement 1C: control of total PMK-1 has not been provided. In addition, the quantification of this blot clearly indicates that there is a huge variation between experiments, and that P-PMK1 variation between conditions is not statistically significant.

I don\'t think this affect the quality of the manuscript, but the author should be accurate in their interpretation, and the their conclusion modified accordingly (subsection "RNP-6 inhibits PMK-1 MAPK signaling"). Similarly, the text should be changed in the Discussion \"How altering splicing can lead to activation of PMK-1....\".

2\) As requested, the authors have performed bacterial lawn occupancy experiments and found it is increased in *rnp-6* G281D mutant compared to WT, which still leaves a doubt on a potential lack of avoidance behavior of the *rnp-6* mutant (rebuttal). Fortunately, the author also provide full lawn survival experiments as requested and found the *rnp-6* G281D and *rnp-6* OE strains to also display Esp compared to WT animals, indicating that these strains indeed have an immune defect. The authors keep describing this immune mechanism as \"resistance\" which I believe is not an appropriate term, especially in this new version of the manuscript where the authors, to answer reviewer 3, now assess the bacterial burden. Resistance, as defined by the capacity to limit bacterial burden, is opposed to tolerance, defined as ability to limit health impact of a given pathogen burden (see Schneider and Ayres Nat Rev Immunol 2008, Medzhitov, Schneider and Soares, Science 2012). In this type of survival assays, where animals are constantly exposed and fed with pathogenic bacteria, it is difficult to assess the resistance capacity. Assessing resistance capacity is easier to detect when animals are transfer onto non-pathogenic food (Sifri et al., Infect Immun 2003). Accordingly, the colonization assays, performed on animals constantly fed for 24h on *S. aureus*, show similar bacterial burden between control and *rnp-6*G281D mutant, *rnp-6* OE strains or *rnp-6* RNAi treated animals (Figure 1---figure supplement 1E, Figure 4---figure supplement 1B-H). Rather, these full lawn survival assays, controlled by similar colonization assays, allow to assess the tolerance capacity of the strains. Together, these results indicate that the immune function of *rnp-6* relies on a tolerance mechanism. This should be indicated in the text which, I believe, would improve the quality of the article. However, the term resistance, which has been repeatedly found though-out the manuscript, is miss-used and should be replaced by i.e.: \"decreased sensitivity\" or \"increased survival\" and only when appropriate, by tolerance. Whether *rnp-6* has also resistance immune branch should not be excluded, as it was difficult to assess in this experimental setting. Please also correct : \"*rnp-6* RNAi did not affect *S. aureus* bacterial burden, suggesting the resistance is caused by independent mechanisms\".

3\) There are still problems with the data presented in Figure 3 and in Figure 3---figure supplement 1. Indeed, there is no demonstration of a correlation between splicing as measured by PCR and using reporter genes. Thus, they neither \"generate this type of reporter for at least one of the genes they identified as undergoing differential splicing\", nor do they provide PCR evidence to support their observations with the *ret-1* reporter. As mCherry and GFP have different half-lives, changes in fluorescence intensity under a pathological situation need not reflect a change in splicing. The magnitude of the change of GFP expression is considerably higher than that of mCherry; it seems that a change in splicing is not the most important effect here. Further, according to the dot plot, the GFP level for the vast majority of \"Infected *rnp-6*\" worms is below that for the majority of \"*rnp-6(dh1127)*\" worms, so the photomicrograph is totally unrepresentative and very misleading.

4\) Statements like, \"By contrast, we observed that the infection sensitive G281D substitution mutant of RNP-6 had a consistently suppressed phosphorylation levels of PMK-1 under *P. aeruginosa* infection condition in multiple biological replicates, although this did not reach statistical significance due variability of phospho-PMK-1 levels between replicates\" are not appropriate. The results are simply not statistically significant and no inferences can be made.

10.7554/eLife.57591.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

> Reviewer \#1:
>
> \[...\] 1) A major concern of this study relays on how survival assay were performed (partial or full lawn) which is not clear and may be of critical importance for the conclusion. Figure 4A: this survival assay testing rnp-6 RNAi was apparently performed using plates with partial lawn of *S. aureus* as the authors state to confirm this result with a survival assay using full lawn plates (subsection "The activity of RNP-6 impairs immunity"). Is the survival assay with partial lawn of *S. aureus* their standard assay ? This need to be clarified in the next and in the Materials and methods. Indeed, it is not clear how the experiments with rnp-6 (dh1127) and rnp-6 (dh1125) in Figure 1H (as well as in Figure 1I-J with other pathogens) and Figure 1---figure supplement 1I, J and K, or with the overexpressing OE strains (Figure 4D) were performed. Indeed, if based on the full lawn assay, the authors can conclude that the rnp-6 RNAi phenotype, which display extend survival compared to control, is not a difference in bacterial exposure, it is not clear whether the phenotypes of rpn-6 G281D mutants or of the OE strains, which display enhanced susceptibility to pathogens (Esp) compared to control, are due to reduced immune response or reduced aversive behavior (and increased bacterial exposure) compared to N2. Full lawn experiment should be performed in order to conclude on the immune role of rnp-6. If partial lawn have been performed, the authors need to compare the bacterial lawn occupancy of RNP-6D281R mutants and the OE strains with N2. The author will be able to conclude on the immune regulatory function of RNP-6 only if RNP-6D281R mutant and N2 have the same avoidance behavior (and been exposed in a similar way to *S. aureus*).

Although we used partial lawn for our standard assays, we also performed the infection survival experiments using full lawn *S. aureus* plates.

![](elife-57591-resp-fig1){#sa2fig1}

Clearly, both *rnp-6(dh1127)* mutants and RNP-6 overexpressing animals exhibit Esp on full lawn *S. aureus* infection plates, indicating that the Esp phenotype cannot be explained by differential exposure to bacteria.We also compared the lawn occupancy of *rnp-6(dh1127)* mutants to N2. We observed a general increase of lawn occupancy in all strains during the course of *S. aureus* infection, which is probably due to physical inactivity caused by advanced infection. Interestingly, *rnp6(1127)* mutants had a higher lawn occupancy compared to N2. This could be explained by the more rapid progression of infection in this strain. Another infection sensitive mutant strain, *pmk-1(km25)*, displayed a similar phenotype, suggesting higher lawn occupancy may be a common phenotype of infection sensitive strains as their physical activity declines faster due to quicker progression of the infection process.

![](elife-57591-resp-fig2){#sa2fig2}

All in all, we conclude that differential exposure to bacteria is not the cause of the Esp phenotype of *rnp-6(dh1127)* and RNP-6 overexpressing animals.

> 2\) As a splicing factor, rpn-6 affects RNA splicing. I believe it would improve the manuscript to specify how primer pairs have been designed so that qPCR experiments reveal an actual change in gene expression and not a change in RNA splicing (Figure 2A).

Special attention was paid to ensure that the qPCR primer binding sites are located in regions which are included in all annotated isoforms. Therefore, the qPCR primers should detect all annotated isoforms and reflect an actual change in gene expression. We provide visualization of all qPCR primer binding sites in the Supplementary file 1. Notes have also been added to the Materials and methods section to clarify this issue.

While we were preparing the lists and the schematics of the primers, we found that the primers for *Y43F8B.9* was mislabeled as *frm-7*. We corrected the corresponding figure in Figure 2---figure supplement 1. This does not affect the conclusion of the study.

> 3\) Figures 5G-H and 6H: condition of these experiments are rather surprising. While most of the pmk-1 and rnp-6 genetic experiment are made in animals infected by *S. aureus*, the authors analyze the effect RNP6 on PMK-1 phosphorylation either in resting condition (RNAi) or during infection by P. aeruginosa. It would greatly increase the quality of the conclusions to show 1) the level of P-PMK1 in N2i and rnp-6i animals infected by S. aureus; 2) the level of P-PMK1 in N2, rnp-6(dh1127) and RNP6 OE strain in the context of *S. aureus* infection. In addition, if anti-pmk1 (Kim et al., 2002) can be obtained, it would be good to blot total pmk-1 to robustly show that variation of P-pmk-1 are really changes in signaling rather a change in total pmk-1 protein level.

We added the total PMK-1 blots for the *rnp-6* and *sfa-1* RNAi Western blots (see Figures 5G and 6H).

We also measured the relative levels of phospho-PMK-1 in *S. aureus* infected animals.

Generally, we did not observe any significant effects of *S. aureus* on the levels of phosphoPMK-1. However, we observed a reduction of phospho-PMK-1 upon *S. aureus* infection in *rnp-6* RNAi treated animals. It seems that the PMK-1 activity is affected by *S. aureus* in an RNP-6 dependent manner.

![](elife-57591-resp-fig3){#sa2fig3}

![](elife-57591-resp-fig4){#sa2fig4}

> 4\) I believe the author should cite the work of the Sasakawa group (Okuda et al., 2005) who had previously identified the Shigella NEL effector IpaH9.8 to bind RNA splicing factor U2AF35 to modulate host immune response. Although IpaH9.8 had later been shown to also target NEMO to control NF-κB and host immune response (Ashida et al. Nat Cell Biol 2010), it was shown that U2AF35 siRNA treatment reduces pro-inflammatory cytokines in Shigella-infected cells HeLa (Okuda et al., 2005). Although this paper show opposite results in term of cytokine expression, it is a first evidence that modulation of a splicing factor, which is related to PUF60, during bacterial infection impacts immune responses, which reinforce the findings of Kew et al.

The reference has been added.

> Reviewer \#2:
>
> \[...\] 1) Stress survival and longevity data -- These assays can be notoriously variable between trials. Therefore, reporting of data from at least three independent trials is customary for these types of studies. The comparisons should be analyzes as individual trials as well as combined. These data can be provided in supporting files.

We provide the p values, number of animals analysed and median survival of all replicates of all infection survival and lifespan experiments in Supplementary file 3.

> 2\) I have concerns over the use of the ret-1 reporter system. It appears that the GFP and RFP are largely expressed is different tissues (head and intestine, respectively) and that the changes in ratio are largely attributed to changes in only GFP versus a true shift from one to the other. The authors should include data for changes in GFP and RFP in addition to the rations. Furthermore, controls for total expression of the reporter would be needed to be sure that these effects are not a reflection of changes in total expression in certain tissues, versus a true shift in splicing within common tissues.

First, we quantified the GFP and mCherry signals from the anterior gut as this is the relevant tissue for bacterial infection in *C. elegans*. Therefore, the quantification reflects a shift of abundance of GFP and mCherry in the same tissue, not a comparison overall.

As the reviewer requested, we provide the quantification of GFP and mCherry separately. Please note that we repeated the infection *ret-1* reporter experiment using a new protocol as suggested by reviewer 3 (with addition of FUDR treatment). The data shown below is the new data.

![](elife-57591-resp-fig5){#sa2fig5}

*S. aureus* infection clearly reduced the GFP to mCherry ratio, and this effect was partially suppressed by the *rnp-6(dh1127)* mutation. GFP intensity decreased drastically in infected N2 but only moderately in infected *rnp-6(dh1127)* animals. mCherry expression was induced by *S. aureus* infection in both WT and *rnp-6(dh1127)* animals. Although we observed a trend of lower mCherry signal in infected *rnp-6(dh1127)* mutants (mean=11.944) compared to infected N2 (mean=12.499), the effect does not reach statistical significance.Similar results can also be seen in *rnp-6* RNAi treated animals. knocking-down *rnp-6* reduced GFP to mCherry ratio, which mimics the situation of infection. *rnp-6* RNAi not only reduced the GFP intensity, but also induced the mCherry signal.

![](elife-57591-resp-fig6){#sa2fig6}
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Based on these data, we conclude that both bacterial infection and *rnp-*6 reduction result in a similar shift of the *ret-1* splicing reporter, which is caused by a decrease of GFP expression and a concomitant increase of mCherry.

> 3\) Figures 5G-H and 6H -- quantification of the representative data for 5H is missing. Also, it is customary to include blots for total PMK-1 to determine if the effects are at the total level or protein modification level.

We did the quantification of phospho-PMK-1 for *P. aeruginosa* infected animals. Although we observed a consistent trend of PMK-1 activation upon *P. aeruginosa* infection in three independent replicates, the relative levels of activation were highly variable and did not reach statistical significance. We moved this data to the figure supplement.
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Further, we added the total PMK-1 blots for the *rnp-6* and *sfa-1* RNAi Western blots (see Figures 5G and 6H).

> Reviewer \#3:
>
> Kew et al. investigate the link between splicing and the immunity and longevity in *C. elegans* and extend their study to a mammalian cell culture model. Because of my expertise, I restrict my comments on the experiments to those using *C. elegans*.
>
> 1\) While the results are intriguing and would be of broad interest, I was concerned by Figure 3F, as in the infected sample, there are clearly larvae hatched inside that have a high GFP level and low mCherry level. This is a real problem. It indicates that (i) the experiments are not properly conducted (ii) the results involving differential splicing could be a result of differences that exist between different stages. Even if the worms shown were exceptional, it is notable that a significant number of the 83 genes alternatively spliced upon *S. aureus* infection in wildtype animals are associated with aldicarb resistance. As alternative splicing is tissue as well as stage specific (e.g. neuron-specific isoforms for many genes), this raises the possibility that the results are due to a differential effect of infection on transcription in a single tissue (including through a general effect on cell viability or developmental speed). The same applies for the effect seen in the rnp-6 mutant; changes in transcription within one tissue, or even subtle changes in developmental stage, would give the same result as alterations in splicing across tissues in an age-synchronized population.

The worms were synchronized with special care, as *rnp-6(dh1127)* has a slight developmental delay. We did the egg lay sequentially to ensure the synchronization of different strains. Animals were also examined visibly before experiments to make sure that they are well-synchronized.

To further exclude the possibility of the effects of staging, we repeated the splicing PCR of *prg-2*, *gyg-1* and *tos-1* on day2 adult animals.

![](elife-57591-resp-fig9){#sa2fig9}

The splicing patterns of day2 adults are generally consistent with those of day 1 young adults, except for *gyg-1*, for which day 2 *rnp-6(dh1127)* animals responded to infection comparably to N2 animals. In day 1 young adults, the *gyg-1* splicing change induced by *S. aureus* infection is partially suppressed in *rnp-6(dh1127)* animals. Because of the special attention given for the synchronization of the animals and the reproducibility of the results in another life stage (Day 2 adulthood), the splicing changes we observed are unlikely to be caused by lack of synchronization or subtle changes in developmental stage, but rather to be the results of infection and/or the *rnp-6* mutation.We also repeated the *ret-1* reporter experiment with FUDR sterilized animals, which eliminates hatching of larvae, and we obtained similar results to the experiments performed without FUDR. We quantified the signals from anterior gut as this is the relevant tissue for bacterial infection in *C. elegans*. See [Author response image 5](#sa2fig5){ref-type="fig"}.

Given the tight staging, it seems less likely that tissue composition is different between genotypes. If there are tissue specific effects (e.g. differential alternative splicing in the nervous system) it still would be due to splicing, and this is inherently interesting, but lies beyond the scope of the study.

> 2\) Given the apparent strong effect on the ret reporter, which presumably should reflect endogenous splicing patterns, how is it that ret-1 was not identified in the sequencing-based analysis? It is unfortunate that the authors did not generated this type of reporter for at least one of the genes they identified as undergoing differential splicing.

First, the RNA sequencing and the *ret-1* reporter imaging were done at different timepoints. We collected the RNA at post-infection 4 hours whereas the imaging of *ret-1* reporter was done at post-infection 9 hours. The effects on *ret-1* maybe a delayed response. To test this hypothesis, we repeated the *ret-1* reporter imaging experiment at post-infection 4 hours.
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At this earlier timepoint, the effects on the *ret=*1 reporter were very small compared to that of the later timepoint, which may be one of the reasons why *ret-1* was not identified in the sequencing-based analysis. Also, the sequencing was done on RNA extracted from the whole animals which may complicate the analysis and average out any tissue specific effects of *ret-1* splicing.

> 3\) Figure 5---figure supplement 1 shows sequencing reads coverage for several genes. If the figure is only matching pairs for their paired end 2x75nt sequencing, which it should be for this type of analysis, the level of intronic signal for several genes is unexpected. So, when they write, \"The splicing patterns of these genes are not significantly affected by *S. aureus* infection or the rnp-6 G281D mutation\", what is the criterion for \"significant\", especially if one looks at the last example, cebp-1, for which there is a stark difference regarding retention of the last intron between wild-type and rnp-6 samples. \[typo: *S. aurues* in figure\]. This is particularly relevant given the known links between cebp-1, its 3\' UTR (pubmed/28673818), pmk-1 (pubmed/27927209) and innate immunity.

q value/p adjusted \< 0.05 is considered to be significant. The following are the additional replicates of the sequencing data of *cebp-1*. The retention of the last intron is variable between biological replicates. Thus, this is likely to be a noise instead of a true biological phenotype.
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> 4\) To understand the basis of altered resistance, it is standard in the field to perform simple tests to assay the extent of bacterial colonization.

We did not observe any observable effects of *rnp-6(dh1127)*, *rnp-6* RNAi or overexpression on *S. aureus* colonization, suggesting that *rnp-6* affects infection resistance through other mechanisms (see Figure 1---figure supplement 1I, Figure 4---figure supplement 1B and H).

> 5\) Interpretation of Figure 2E is complicated by the fact that the constitutive expression level of at least one of the genes under study differs between wild-type and mutant worms. Thus, for nlp-30, there is the same fold-change after infection in mutant and wild-type, so the induction is not rnp-6 dependent. One therefore wonders whether their strategy for gene selection (Figure 2C) is entirely appropriate.

The relative levels of *nlp-30* are lower in *rnp-6(dh1127)* mutants regardless of infection, suggesting that the expression of *nlp-30* is dependent on *rnp-6* under both basal and infection conditions. *nlp-30* is still induced in infected *rnp-6(dh1127)* animals, suggesting that the mutation does not completely inhibit the induction of *nlp-30* by infection. The mutated RNP-6 may still mediate the induction of *nlp-30*. Alternatively, there may be alternative and/or compensatory mechanisms to regulate the expression of *nlp-30* in *rnp-6(dh1127)* animals. Nevertheless, the data supports that *rnp-6* affects the expression of *nlp-30*, and also additional regulation exists.

\[Editors' note: what follows is the authors' response to the second round of review.\]

> Essential revisions:
>
> 1\) Despite the additional data provided, it is still not clear how RNP-6 impacts the PMK-1 pathway during *S. aureus* and *P. aeruginosa* infection. \"RNP-6 exerts its inhibitory effects on immunity by suppressing the activity of PMK-1\" (L 305-306) is over-stated as the authors do not have proof that rnp-6 impact the activation (phosphorylation) of PMK-1 during infection. Indeed:
>
> -- The authors find no effect of rnp-6 OE strain or rnp-6 G281D mutant on the phospho-level of PMK-1 during *S. aureus* infection (rebuttal experiment).
>
> -- The authors state that rnp-6 RNAi reduces P-PMK-1 during *S. aureus* infection, but this result is rather questionable considering the western-blot shown (rebuttal). There are huge differences in total protein levels as revealed by the loading control (actin), but these differences are not as strong in total PMK-1. This either suggest that 1) that the level of total PMK-1 varies, or 2) the experiment is not well conducted.
>
> -- Figure 5---figure supplement 1C: control of total PMK-1 has not been provided. In addition, the quantification of this blot clearly indicates that there is a huge variation between experiments, and that P-PMK1 variation between conditions is not statistically significant.
>
> I don\'t think this affect the quality of the manuscript, but the author should be accurate in their interpretation, and the their conclusion modified accordingly (subsection "RNP-6 inhibits PMK-1 MAPK signaling"). Similarly, the text should be changed in the Discussion \"How altering splicing can lead to activation of PMK-1....\".

We consulted other experts from the field concerning pathogen dependent PMK-1 phosphorylation. Although it is well known that *pmk-1* is required for resistance to bacterial pathogens in *C. elegans*, and mutations or treatments that induce phosphorylation of PMK-1 lead to enhanced survival (Cao and Aballay, 2016; Kim et al., 2004; Park et al., 2018; Pukkila-Worley et al., 2012; Sun et al., 2011; Xiao et al., 2020), whether bacterial pathogens actually induce phosphorylation of PMK-1 is debated.

*S. aureus* does not activate PMK-1 phosphorylation (Dr. Javier Irazoqui, personal communications), which we also confirmed. On the other hand, PA14 infection leads to high variability of phospho-PMK-1 levels (Dr. Read Pukkilla-Worley, personal communication), which is also consistent with our data. Conceivably these differences might reflect differences in timing, or culture conditions.

Therefore, the absence of PMK-1 phosphorylation upon infection is not inconsistent with previous findings, and does not compromise the results from survival epistasis and phosphoPMK-1 blots of *rnp-6i* treated animals, which indicate *pmk-1* acts downstream of *rnp-6*.

We have modified the Discussion section according to the reviewers' suggestions.

> 2\) As requested, the authors have performed bacterial lawn occupancy experiments and found it is increased in rnp-6 G281D mutant compared to WT, which still leaves a doubt on a potential lack of avoidance behavior of the rnp-6 mutant (rebuttal). Fortunately, the author also provide full lawn survival experiments as requested and found the rnp-6 G281D and rnp-6 OE strains to also display Esp compared to WT animals, indicating that these strains indeed have an immune defect. The authors keep describing this immune mechanism as \"resistance\" which I believe is not an appropriate term, especially in this new version of the manuscript where the authors, to answer reviewer 3, now assess the bacterial burden. Resistance, as defined by the capacity to limit bacterial burden, is opposed to tolerance, defined as ability to limit health impact of a given pathogen burden (see Schneider and Ayres Nat Rev Immunol 2008, Medzhitov, Schneider and Soares, Science 2012). In this type of survival assays, where animals are constantly exposed and fed with pathogenic bacteria, it is difficult to assess the resistance capacity. Assessing resistance capacity is easier to detect when animals are transfer onto non-pathogenic food (Sifri et al., Infect Immun 2003). Accordingly, the colonization assays, performed on animals constantly fed for 24h on *S. aureus*, show similar bacterial burden between control and rnp-6G281D mutant, rnp-6 OE strains or rnp-6 RNAi treated animals (Figure 1---figure supplement 1E, Figure 4---figure supplement 1B-H). Rather, these full lawn survival assays, controlled by similar colonization assays, allow to assess the tolerance capacity of the strains. Together, these results indicate that the immune function of rnp-6 relies on a tolerance mechanism. This should be indicated in the text which, I believe, would improve the quality of the article. However, the term resistance, which has been repeatedly found though-out the manuscript, is miss-used and should be replaced by i.e.: \"decreased sensitivity\" or \"increased survival\" and only when appropriate, by tolerance. Whether rnp-6 has also resistance immune branch should not be excluded, as it was difficult to assess in this experimental setting. Please also correct : \"rnp-6 RNAi did not affect *S. aureus* bacterial burden, suggesting the resistance is caused by independent mechanisms\".

We thank the reviewers for pointing out the difference between resistance and tolerance/survival. We have modified the manuscript by omitting the word pathogen resistance, as suggested.

> 3\) There are still problems with the data presented in Figure 3 and in Figure 3---figure supplement 1. Indeed, there is no demonstration of a correlation between splicing as measured by PCR and using reporter genes. Thus, they neither \"generate this type of reporter for at least one of the genes they identified as undergoing differential splicing\", nor do they provide PCR evidence to support their observations with the ret-1 reporter. As mCherry and GFP have different half-lives, changes in fluorescence intensity under a pathological situation need not reflect a change in splicing. The magnitude of the change of GFP expression is considerably higher than that of mCherry; it seems that a change in splicing is not the most important effect here. Further, according to the dot plot, the GFP level for the vast majority of \"Infected rnp-6\" worms is below that for the majority of \"rnp-6(dh1127)\" worms, so the photomicrograph is totally unrepresentative and very misleading.

Because this reporter had been previously published as reflecting splicing (Heintz et al., 2017; Kuroyanagi et al., 2013), we took it at face value, but are grateful that the reviewers pointed out possible different interpretations of this reporter.

To address the reviewers' concerns, we performed RT-PCR to assess the relative abundance of the two isoforms of *ret-1*. (see Figure 4C and D, Figure 4---figure supplement 1D).

First, we confirmed that both *rnp-6* RNAi and *S. aureus* infection induced *ret-1* exon 5

skipping, although the effects seem to be less dramatic as indicated by the reporter system, suggesting that the splicing reporter might not truly reflect the splicing of the endogenous *ret-1* transcript.

Furthermore, we observed that the *rnp-6(dh1127)* mutation did not inhibit the infection induced splicing of *ret-1*. Rather, the basal level of exon 5 skipping is slightly elevated in the *rnp-6* mutants. These observations were not reflected by the splicing reporter.

Multiple explanations could potentially account for the discrepancy of the two methods. First, we focused on a specific tissue (anterior gut) for the splicing reporter experiments whereas RT-PCR reflects the splicing events averaged over the whole animals. Second, some elements, such as splicing enhancers, may not be included into the reporter, which can lead to different splicing patterns compared to endogenous *ret-1* transcript. And finally, the signals from the reporter might reflect other processes, including mRNA and/or protein stability, translation and protein degradation.

We conclude that the *ret-1* splicing reporter does not accurately reflect the splicing of *ret-1* endogenous transcript. Therefore, we decided to remove the relevant data from the manuscript (Figure 3E and Figure 4C).

To replace Figure 4C, we checked how *rnp-6* RNAi affects the splicing (as measured by RTPCR) of *prg-2*, *gyg-1* and *tos-1*, which we identified to show *rnp-6* G281D dependence upon infection (Figure 3) (see Figure 4C and D and Figure 4---figure supplement 1D).

We observed that *rnp-6* RNAi affected *prg-2* and *tos-1* splicing, but had no observable effect on *gyg-1*. *rnp-6* RNAi promoted the splicing of *prg-2* intron 1, similar to the effect of *S. aureus* infection (Figure 3B), but opposite to *rnp-6 G281D* mutant. On the other hand, *rnp-6* RNAi inhibited the splicing of *tos-1* intron 1, and this splicing pattern was similar to what we observed for the *rnp-6* G281D mutant (Figure 3D).

In conclusion, the *rnp-6* G281D mutation inhibits infection induced *prg-2* intron 1 splicing, whereas *rnp-6* RNAi promotes the splicing event. In this regard, the *rnp-6* G281D mutation resembles a gain-of function. However, both *rnp-6* G281D and *rnp-6* RNAi reduce the splicing of *tos-1* intron 1. Therefore, the G281D mutation and *rnp-6* RNAi result in partially opposite and also overlap splicing, similar to the results of transcript abundance of immune-genes (Figure 4---figure supplement 1). Nevertheless, these results confirm that *rnp-6* RNAi affects splicing of the genes whose splicing is moderated by infection, strengthening the role of RNP-6 in infection induced splicing remodeling.

> 4\) Statements like, \"By contrast, we observed that the infection sensitive G281D substitution mutant of RNP-6 had a consistently suppressed phosphorylation levels of PMK-1 under *P. aeruginosa* infection condition in multiple biological replicates, although this did not reach statistical significance due variability of phospho-PMK-1 levels between replicates\" are not appropriate. The results are simply not statistically significant and no inferences can be made.

As discussed, phospho-PMK-1 levels upon infection can be very variable. We removed this data from the manuscript.
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